Wenlan Zhou

832 total citations · 1 hit paper
45 papers, 559 citations indexed

About

Wenlan Zhou is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wenlan Zhou has authored 45 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Wenlan Zhou's work include Medical Imaging Techniques and Applications (12 papers), Peptidase Inhibition and Analysis (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Wenlan Zhou is often cited by papers focused on Medical Imaging Techniques and Applications (12 papers), Peptidase Inhibition and Analysis (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Wenlan Zhou collaborates with scholars based in China, United States and Czechia. Wenlan Zhou's co-authors include Hubing Wu, Quanshi Wang, Hongsheng Li, Yanjiang Han, Shun Huang, Lijuan Wang, Qiaoyu Wang, Ying Tian, Ganghua Tang and Kongzhen Hu and has published in prestigious journals such as Radiology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Wenlan Zhou

43 papers receiving 555 citations

Hit Papers

Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluat... 2022 2026 2023 2024 2022 25 50 75 100

Peers

Wenlan Zhou
Wenlan Zhou
Citations per year, relative to Wenlan Zhou Wenlan Zhou (= 1×) peers Yong-Wen Song

Countries citing papers authored by Wenlan Zhou

Since Specialization
Citations

This map shows the geographic impact of Wenlan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlan Zhou more than expected).

Fields of papers citing papers by Wenlan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenlan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlan Zhou. The network helps show where Wenlan Zhou may publish in the future.

Co-authorship network of co-authors of Wenlan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Wenlan Zhou. A scholar is included among the top collaborators of Wenlan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenlan Zhou. Wenlan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Kun, Jing Li, Hao Zhang, et al.. (2025). Intratumoral and peritumoral PET/CT-based radiomics for non-invasively and dynamically predicting immunotherapy response in NSCLC. British Journal of Cancer. 132(6). 558–568. 8 indexed citations
2.
Xie, Fei, Ye Dong, Kemin Zhou, et al.. (2025). First clinical investigation to predict lymphovascular and/or perineural invasion in gastric cancer using 18F-FAPI-42 PET/CT parameters. European Journal of Nuclear Medicine and Molecular Imaging. 52(13). 4778–4787. 1 indexed citations
3.
Zhou, Wenlan, et al.. (2024). Superiority of 18F-FAPI-42 PET/CT in Eosinophilic Gastrointestinal Disorders. Clinical Nuclear Medicine. 50(7). e440–e442.
4.
Zhou, Wenlan, Lu Bai, Jiawen Huang, et al.. (2023). Pharmacokinetic analysis of 6-O-[18F]FEE for PET imaging of EGFR mutation. Bioorganic & Medicinal Chemistry Letters. 85. 129217–129217. 1 indexed citations
5.
Zhou, Wenlan, et al.. (2023). Metastatic melanoma extending along the inferior vena cava to its branches and venous plexus: a rare route metastasis characterized by [18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 50(10). 3149–3150.
6.
Zhou, Wenlan & Hubing Wu. (2023). Unexpected Origin of Lung Metastases. Clinical Nuclear Medicine. 48(8). e393–e395. 2 indexed citations
7.
Wang, Lijuan, Ganghua Tang, Kongzhen Hu, et al.. (2022). Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancer. Radiology. 303(1). 191–199. 117 indexed citations breakdown →
8.
Cheng, Nai‐Ming, Jiawen Yao, Jinzheng Cai, et al.. (2021). Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging. Clinical Cancer Research. 27(14). 3948–3959. 36 indexed citations
9.
Zhou, Wenlan, Shun Huang, Yan‐Ping Jiang, et al.. (2021). Automatic radiosynthesis and preclinical evaluation of 18F-AlF-PSMA-NF as a potential PET probe for prostate cancer imaging. Amino Acids. 53(6). 929–938. 4 indexed citations
10.
Jiang, Maoqing, et al.. (2021). Report of Eleven Patients of Subcutaneous Panniculitis-Like T-Cell Lymphoma: Clinicopathologic Features, 18F-FDG PET/CT Findings and Outcome. Frontiers in Oncology. 11. 650822–650822. 7 indexed citations
11.
Gu, Jiamei, Wenlan Zhou, Lijuan Wang, et al.. (2020). Benefits of 18F-FDG PET/CT for the preoperative characterisation or staging of disease in the ampullary and duodenal papillary. European Radiology. 30(9). 5089–5098. 7 indexed citations
12.
Wang, Lijuan, et al.. (2019). Gummatous Syphilis Mimicking Malignant Bone Tumor on FDG PET/CT. Clinical Nuclear Medicine. 44(4). 313–316. 6 indexed citations
13.
Guan, Wei, Hubing Wu, Quanshi Wang, et al.. (2017). Utility of Maximum Standard Uptake Value as a Predictor for Differentiating the Invasiveness of T1 Stage Pulmonary Adenocarcinoma. Clinical Lung Cancer. 19(3). 221–229. 8 indexed citations
14.
Jiang, Maoqing, Tianfu Li, Liyun Wu, et al.. (2017). Interim 18F-FDG PET/CT and BCL2 for predicting the prognosis of patients with diffuse large B-cell lymphoma in the rituximab era. Nuclear Medicine Communications. 39(2). 147–153. 4 indexed citations
15.
Liu, Wenjuan, Quanshi Wang, Hubing Wu, Yanjiang Han, & Wenlan Zhou. (2016). Establishment of a diagnostic model for charactering solitary pulmonary nodule based on 18F-FDG PET/CT and clinical data. 36(3). 211–215. 1 indexed citations
16.
Wang, Lijuan, Hubing Wu, Yanjiang Han, et al.. (2015). Utility of F-18 FDG PET/CT on the evaluation of primary bone lymphoma. European Journal of Radiology. 84(11). 2275–2279. 13 indexed citations
17.
Zhou, Wenlan, et al.. (2014). Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis. Nuclear Medicine Communications. 35(11). 1107–1111. 15 indexed citations
18.
Wu, Hubing, et al.. (2011). Preliminary Study on the Evaluation of Olfactory Neuroblastoma Using PET/CT. Clinical Nuclear Medicine. 36(10). 894–898. 10 indexed citations
19.
Wu, Hubing, et al.. (2011). F-18 FDG in Conjunction With 11C-Choline PET/CT in the Diagnosis of Hepatocellular Carcinoma. Clinical Nuclear Medicine. 36(12). 1092–1097. 40 indexed citations
20.
Ye, Xianghua, Longhua Chen, Hubing Wu, et al.. (2010). 18F-FDG PET/CT Evaluation of Lymphoma with Renal Involvement: Comparison with Renal Carcinoma. Southern Medical Journal. 103(7). 642–649. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026